Latest & greatest articles for cerebral palsy

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on cerebral palsy or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on cerebral palsy and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for cerebral palsy

1. Selective dorsal rhizotomy for treatment of spasticity in cerebral palsy

Selective dorsal rhizotomy for treatment of spasticity in cerebral palsy NHS England » Selective dorsal rhizotomy for treatment of spasticity in cerebral palsy Search Search Menu Selective dorsal rhizotomy for treatment of spasticity in cerebral palsy Document first published: 19 March 2019 Page updated: 20 August 2019 Topic: Publication type: Selective dorsal rhizotomy is an operation used to reduce spasticity (muscle stiffness) in cerebral palsy. NHS England has carefully reviewed

2019 NHS England

2. Botulinum toxin A for focal spasticity of the upper or lower limbs in children with cerebral palsy

Botulinum toxin A for focal spasticity of the upper or lower limbs in children with cerebral palsy '); } else { document.write(' '); } ACE | Botulinum toxin A for treating focal spasticity of the upper or lower limbs in children with cerebral palsy Search > > Botulinum toxin A for treating focal spasticity of the upper or lower limbs in children with cerebral palsy - Botulinum toxin A for treating focal spasticity of the upper or lower limbs in children with cerebral palsy Published on 2 (...) September 2019 Guidance Recommendations The Ministry of Health's Drug Advisory Committee has recommended: Clostridium botulinum toxin type A neurotoxin complex (Botox) 50 U and 100 U injection vials for treating children, aged 2 years or older, with focal spasticity of the upper or lower limbs (including dynamic equinus foot deformity) due to cerebral palsy, and who: do not have significant joint contractures, i.e. the affected joint is not permanently fixed in position due to shortening of the target

2019 Appropriate Care Guides, Agency for Care Effectiveness (Singapore)

3. Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy. (Abstract)

Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy. Cerebral palsy (CP) is the most common cause of physical disabilities in children in high-income countries. Spasticity is the most common motor disturbance in CP. Botulinum toxin type A (BoNT-A) is considered the first-line treatment for focal spasticity in people with CP.To evaluate the effectiveness and safety of BoNT-A compared to other treatments used in the management of lower limb spasticity

2019 Cochrane

4. Care Coordination and Funding of Pediatric Cerebral Palsy in Canada

Care Coordination and Funding of Pediatric Cerebral Palsy in Canada Care Coordination and Funding of Pediatric Cerebral Palsy in Canada | CADTH.ca Find the information you need Care Coordination and Funding of Pediatric Cerebral Palsy in Canada Care Coordination and Funding of Pediatric Cerebral Palsy in Canada Last updated: August 28, 2019 Project Number: ES0340-000 Product Line: Result type: Report Expected Completion Date: March 13, 2020 CADTH is undertaking an Environmental Scan (...) of the models of care coordination and funding that are in place in Canada for children and adolescents living with cerebral palsy (CP). This project is being conducted to help inform decision-making and to support the implementation of best practices to improve the health and well-being of children living with CP. The key objectives of this Environmental Scan are to: determine the current state of care and funding for children and adolescents living with CP in Canada identify and describe the models

2019 Canadian Agency for Drugs and Technologies in Health - Environmental Scanning

5. Prevalence of Mental Health Disorders Among Adults With Cerebral Palsy: A Cross-sectional Analysis. (Abstract)

Prevalence of Mental Health Disorders Among Adults With Cerebral Palsy: A Cross-sectional Analysis. Persons with cerebral palsy (CP) have an increased risk for secondary chronic conditions during childhood, including mental health disorders. However, little is known about how these disorders affect adults with CP.To determine the prevalence of mental health disorders among adults with CP compared with those without CP.Cross-sectional.2016 Optum Clinformatics Data Mart.8.7 million adults

2019 Annals of Internal Medicine

6. The Effect of Intrathecal Baclofen in Dyskinetic Cerebral Palsy: The IDYS Trial Full Text available with Trip Pro

The Effect of Intrathecal Baclofen in Dyskinetic Cerebral Palsy: The IDYS Trial Intrathecal baclofen treatment is used for the treatment of dystonia in patients with severe dyskinetic cerebral palsy; however, the current level of evidence for the effect is low. The primary aim of this study was to provide evidence for the effect of intrathecal baclofen treatment on individual goals in patients with severe dyskinetic cerebral palsy.This multicenter, randomized, double-blind, placebo-controlled (...) trial was performed at 2 university medical centers in the Netherlands. Patients with severe dyskinetic cerebral palsy (Gross Motor Functioning Classification System level IV-V) aged 4 to 24 years who were eligible for intrathecal baclofen were included. Patients were assigned by block randomization (2:2) for treatment with intrathecal baclofen or placebo for 3 months via an implanted microinfusion pump. The primary outcome was goal attainment scaling of individual treatment goals (GAS T score

2019 EvidenceUpdates

7. Efficacy of Armeo® Robotic Therapy Versus Conventional Therapy on Upper Limb Function in Children With Hemiplegic Cerebral Palsy. (Abstract)

Efficacy of Armeo® Robotic Therapy Versus Conventional Therapy on Upper Limb Function in Children With Hemiplegic Cerebral Palsy. The aim of this study was to examine the efficacy of Armeo robotic therapy, compared with conventional therapy, on upper limb function in children with hemiplegic cerebral palsy.Thirty children with hemiplegic cerebral palsy, with ages ranging from 6 to 8 yrs, were selected for this randomized controlled study and randomly assigned to two groups. The study group (n (...) Ashworth Scale scores for the study and control groups were 1.6 (0.3) and 2 (0.5), respectively. Postinterventional Quality of Upper Extremity Skills Test total scores for the study and control groups were 84.6 (2.7) and 79.1 (2), respectively.Armeo robotic therapy is significantly more effective than conventional therapy in improving the upper limb quality of movement in children with hemiplegic cerebral palsy.

2019 American journal of physical medicine & rehabilitation Controlled trial quality: uncertain

8. Cerebral palsy

Cerebral palsy Cerebral palsy - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Cerebral palsy Last reviewed: February 2019 Last updated: February 2019 Summary An umbrella term referring to a non-progressive disease of the brain originating during the antenatal, neonatal, or early postnatal period when brain neuronal connections are still evolving. Most common cause of childhood disability affecting 2.5 per 1000 (...) , and extremity deformity. Definition Cerebral palsy (CP) is an umbrella term referring to a non-progressive disease of the brain originating during the antenatal, neonatal, or early postnatal period when brain neuronal connections are still evolving. Rosenbaum P, Paneth N, Leviton A, et al. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl. 2007 Feb;109:8-14. http://www.ncbi.nlm.nih.gov/pubmed/17370477?tool=bestpractice.com Secondary effects of spasticity

2019 BMJ Best Practice

9. Preliminary study of the effect of training with a gaming balance board on balance control in children with cerebral palsy: a randomized controlled trial. (Abstract)

Preliminary study of the effect of training with a gaming balance board on balance control in children with cerebral palsy: a randomized controlled trial. A new protocol based on the use of a gaming balance board for children with cerebral palsy was tested.A total of 56 children with cerebral palsy were enrolled and randomly divided into two groups: experimental and control. The children in experimental group underwent 12 weeks of rehabilitation using their foot to play personal computer games (...) , P = .011; sway area, F = 11.79, P = .001) and improved the performance of the functional balance tests.This study demonstrated the possibility that this new gaming balance board can be used for balance control in children with cerebral palsy.

2019 American journal of physical medicine & rehabilitation Controlled trial quality: uncertain

10. Cerebral palsy in adults

, despite having enteral anti-dystonic drug treatment or botulinum toxin type A [5] treatment. Provide information and discuss the procedure, including intrathecal baclofen testing, with the person (and their family or carer, if agreed) as described in recommendations 1.3.13 to 1.3.16. Deep br Deep brain stimulation ain stimulation 1.3.25 If adults with cerebral palsy continue to have severe and painful dystonia, despite having enteral anti-dystonic drug treatment or botulinum toxin type A treatment (...) , consider referring them to a specialised centre with experience in providing deep brain stimulation. See also NICE interventional procedures guidance on deep brain stimulation for tremor and dystonia (excluding Parkinson's diseas). Cerebral palsy in adults (NG119) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 19 of 64T o find out why the committee made the recommendations on neurosurgical treatments to reduce

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

11. Does Home-Based Progressive Resistance or High-Intensity Circuit Training Improve Strength, Function, Activity or Participation in Children With Cerebral Palsy? (Abstract)

Does Home-Based Progressive Resistance or High-Intensity Circuit Training Improve Strength, Function, Activity or Participation in Children With Cerebral Palsy? Does home-based progressive resistance or high-intensity circuit training improve strength, function, activity, or participation in children with cerebral palsy (CP)?This was the first study on high-intensity circuit training for children with CP. This study was conducted as a randomized prospective controlled pilot study.Evaluation

2019 EvidenceUpdates

12. Cerebral palsy

of cerebral palsy include: Brain tumour — suggested by acute presentation with headache, other signs and symptoms of raised intracranial pressure (such as early morning vomiting), seizures, and focal neurological deficits, following initially normal development. Dystonia — suggested by onset of muscular deformity after several years of normal development. Presents with sustained periods of muscle contraction and dystonia (movements can be abrupt and violent). Contractures are absent. There may (...) Cerebral palsy Cerebral palsy - NICE CKS Share Cerebral palsy: Summary Cerebral palsy (CP) is an umbrella term for a group of permanent movement and posture disorders that limit activity. The undelying cause is an acquired pathology within the developing brain during the prenatal, neonatal, or early infant period. The impaired movement associated with CP results from centrally-mediated abnormal muscle tone which leads (most commonly) to spasticity. CP can also incorporate disorders of sensation

2019 NICE Clinical Knowledge Summaries

13. Single Event Multi-Level Surgeries for Children, Adolescents, and Young Adults with Cerebral Palsy or Other Similar Neuromotor Conditions

, Definitions for terms marked with *, and How to Cite this Guideline may be found in the Appendices. INTRODUCTION / BACKGROUND Cerebral Palsy (CP) is a disorder of movement and posture caused by a static, non-progressive, neurological incident, occurring in the fetal or infant brain. As a result, individuals often have secondary impairments including musculoskeletal pathologies consisting of abnormal muscle tone, loss of selective motor control, impaired balance, impaired posture, and impaired mobility (...) Single Event Multi-Level Surgeries for Children, Adolescents, and Young Adults with Cerebral Palsy or Other Similar Neuromotor Conditions Evidence-Based Clinical Care Guideline for Physical Therapy Management of Single Event Multi-Level Surgeries for Children, Adolescents, and Young Adults with Cerebral Palsy or Other Similar Neuromotor Conditions Guideline (48) Copyright © 2018 Cincinnati Children's Hospital Medical Center; all rights reserved. Page 1 of 33 February 6, 2019 Abbreviations

2019 Cincinnati Children's Hospital Medical Center

14. The carry-over effect of an aquatic-based intervention in children with cerebral palsy Full Text available with Trip Pro

The carry-over effect of an aquatic-based intervention in children with cerebral palsy Cerebral palsy (CP) is the most common motor disability in childhood. Children with CP are more likely to have lower levels of physical activity than their peers, which has negative implications for their health. However, aquatic exercise can be used to improve levels of fitness among children with CP.To determine the carry-over effect of an aquatic-based programme (postural control and balance) on land

2018 African journal of disability Controlled trial quality: uncertain

15. Cerebral palsy

, diplegias, cerebral palsies , Little disease, Little's disease Files Rapid Response Reference List Published : January 18, 2017 Follow us: © 2017 Canadian Agency for Drugs and Technologies in Health Get our newsletter: 2017 9. Intrathecal baclofen for treating spasticity in children with cerebral palsy . BACKGROUND: Cerebral palsy is a disorder of movement and posture arising from a non-progressive lesion in the developing brain. Spasticity, a disorder of increased muscle tone, is the most common motor (...) 2018 Summary An umbrella term referring to a non-progressive disease of the brain originating during the antenatal, neonatal, or early postnatal period when brain neuronal connections are still evolving. Most common cause of childhood disability affecting 2.5 per 1000 individuals (...) deformity. Definition Cerebral palsy (CP) is an umbrella term referring to a non-progressive disease of the brain originating during the antenatal, neonatal, or early postnatal period when brain neuronal connections

2018 Trip Latest and Greatest

16. Cerebral palsy

Cerebral palsy Evidence Maps - Trip Database or use your Google+ account Liberating the literature ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4

2018 Trip Evidence Maps

17. Neonatal interventions for preventing cerebral palsy: an overview of Cochrane Systematic Reviews. Full Text available with Trip Pro

Neonatal interventions for preventing cerebral palsy: an overview of Cochrane Systematic Reviews. Cerebral palsy is an umbrella term that encompasses disorders of movement and posture attributed to non-progressive disturbances occurring in the developing foetal or infant brain. As there are diverse risk factors and aetiologies, no one strategy will prevent cerebral palsy. Therefore, there is a need to systematically consider all potentially relevant interventions for prevention.PrimaryTo (...) summarise the evidence from Cochrane Systematic Reviews regarding effects of neonatal interventions for preventing cerebral palsy (reducing cerebral palsy risk).SecondaryTo summarise the evidence from Cochrane Systematic Reviews regarding effects of neonatal interventions that may increase cerebral palsy risk.We searched the Cochrane Database of Systematic Reviews (27 November 2016) for reviews of neonatal interventions reporting on cerebral palsy. Two review authors assessed reviews for inclusion

2018 Cochrane

18. An ultrasonographic analysis of the activation patterns of abdominal muscles in children with spastic type cerebral palsy and in typically developing individuals: a comparative study Full Text available with Trip Pro

An ultrasonographic analysis of the activation patterns of abdominal muscles in children with spastic type cerebral palsy and in typically developing individuals: a comparative study Abdominal muscles have stiffer appearance in individuals with spastic type cerebral palsy (STCP) than in their typically developing (TD) peers. This apparent stiffness has been implicated in pelvic instability, mal-rotation, poor gait and locomotion. This study was aimed at investigating whether abdominal muscles

2018 Archives of physiotherapy

19. Addition of an educational programme for primary caregivers to rehabilitation improves self-care and mobility in children with cerebral palsy: a randomized controlled trial (Abstract)

Addition of an educational programme for primary caregivers to rehabilitation improves self-care and mobility in children with cerebral palsy: a randomized controlled trial To assess whether the addition of an education programme for primary caregivers to rehabilitation improves daily functioning in children with cerebral palsy.A randomized, single-blind, controlled study.This study was conducted in a rehabilitation centre in Salvador, Brazil.A total of 63 boys and girls with cerebral palsy (...) ) and the mobility domain of the Caregiver Assistance Scale of Pediatric Evaluation of Disability Inventory (mean change 0.87 versus 17.88; P = 0.002).Self-care and mobility improved in children with cerebral palsy with the addition to conventional rehabilitation of an educational programme for primary caregivers.

2018 EvidenceUpdates

20. A randomized controlled trial to compare two methods of constraint-induced movement therapy to improve functional ability in the affected upper limb in pre-school children with hemiplegic cerebral palsy: CATCH TRIAL Full Text available with Trip Pro

A randomized controlled trial to compare two methods of constraint-induced movement therapy to improve functional ability in the affected upper limb in pre-school children with hemiplegic cerebral palsy: CATCH TRIAL To determine the feasibility and short-term efficacy of caregiver-directed constraint-induced movement therapy to improve upper limb function in young children with hemiplegic cerebral palsy.Randomized controlled trial with masked assessment.Community paediatric therapy services.Pre (...) -school children with hemiplegic cerebral palsy.Caregiver-directed constraint-induced movement therapy administered using either 24-hour short-arm restraint device (prolonged) or intermittent holding restraint during therapy (manual).Primary measures include Assisting Hand Assessment (AHA) at 10 weeks. Secondary measures include adverse events, Quality of Upper Extremity Skills Test and Pediatric Quality of Life Inventory. Feasibility measures include recruitment, retention, data completeness

2018 EvidenceUpdates